Li, Weiping <br/><br/>
Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors.  [electronic resource] 

 -  Journal of hematology & oncology  07 2019 
 - 73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1756-8722 
<br/><br/><label>Standard No.: </label>10.1186/s13045-019-0761-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Cell Survival<br/>Female<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--genetics<br/>Male<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Proto-Oncogene Proteins c-bcl-6--metabolism<br/>Proto-Oncogene Proteins c-myc--metabolism<br/>Transfection